Novo Nordisk to Cut Ozempic Price for Some Canadians Amid Launch of Generic Alternatives

Novo Nordisk to Cut Ozempic Price for Some Canadians Amid Launch of Generic Alternatives
The injectable drug Ozempic, a diabetes medication sometimes prescribed off-label for weight loss, is shown in Houston on July 1, 2023. David J. Phillip/File/AP Photo
|Updated:
0:00

Novo Nordisk says it will offer lower-priced Ozempic to some Canadian customers through a new savings program as generic versions of the diabetes and weight-loss drug enter the Canadian market.

Eligible Canadians without public or private drug coverage will be able to buy Ozempic for a lower price at pharmacies outside of Quebec using a savings card, the company said in a news release on May 26.
Google LogoMark Us Preferred on Google
William Hetherington
William Hetherington
Author
William Hetherington is a news reporter with the Canadian edition of The Epoch Times.